[Inhibition of uterine contraction. Several aspects and relationships with cyclic AMP].
D000328:Adult; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism*; D004336:Drug Antagonism; D005260:Female; D005318:Fetal Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D009921:Metaproterenol / Q000494:pharmacology*; D009130:Muscle, Smooth / Q000378:metabolism; D010121:Oxytocin / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011247:Pregnancy; D051381:Rats; D013806:Theophylline / Q000494:pharmacology*; D014599:Uterus / Q000187:drug effects* / Q000378:metabolism
D010121:Oxytocin; D009921:Metaproterenol; D013806:Theophylline; D000242:Cyclic AMP; D010646:Phentolamine
Inhibition de la contraction utérine. Quelques aspects et rapports avec l'AMPc.